Dashboard
Manage Tickers

EXPE Expedia Group, Inc.

Nasdaq expediagroup.com


$ 225.51 $ 0.25 (0.11 %)    

Wednesday, 22-Oct-2025 19:22:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.27 $ -5.89 (-0.96 %)
DIA $ 464.98 $ -3.44 (-0.73 %)
SPY $ 666.76 $ -3.49 (-0.52 %)
TLT $ 92.19 $ 0.06 (0.07 %)
GLD $ 376.01 $ 0.04 (0.01 %)
$ 226.39
$ 225.40
$ 220.00 x 1
$ 226.90 x 35
$ 224.12 - $ 227.87
$ 129.46 - $ 240.98
1,310,127
na
28.01B
$ 1.50
$ 25.16
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-06-2025 12-31-2024 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-02-2024 03-31-2024 10-Q
7 02-09-2024 12-31-2023 10-K
8 11-02-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-05-2023 03-31-2023 10-Q
11 02-10-2023 12-31-2022 10-K
12 11-04-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-02-2022 03-31-2022 10-Q
15 02-10-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 05-07-2021 03-31-2021 10-Q
19 02-12-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 07-31-2020 06-30-2020 10-Q
22 05-21-2020 03-31-2020 10-Q
23 02-14-2020 12-31-2019 10-K
24 11-07-2019 09-30-2019 10-Q
25 07-25-2019 06-30-2019 10-Q
26 05-03-2019 03-31-2019 10-Q
27 02-08-2019 12-31-2018 10-K
28 10-26-2018 09-30-2018 10-Q
29 07-27-2018 06-30-2018 10-Q
30 04-27-2018 03-31-2018 10-Q
31 02-09-2018 12-31-2017 10-K
32 10-27-2017 09-30-2017 10-Q
33 07-28-2017 06-30-2017 10-Q
34 04-28-2017 03-31-2017 10-Q
35 02-10-2017 12-31-2016 10-K
36 10-28-2016 09-30-2016 10-Q
37 07-29-2016 06-30-2016 10-Q
38 04-29-2016 03-31-2016 10-Q
39 02-11-2016 12-31-2015 10-K
40 10-30-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

wedbush-maintains-neutral-on-expedia-group-raises-price-target-to-230
Wedbush Maintains Neutral on Expedia Group...
10/22/2025 15:52:30

Wedbush analyst Scott Devitt maintains Expedia Group (NASDAQ:EXPE) with a Neutral and raises the price target from $220 to $...

Core News & Articles
Webus International Announces Its Wetour P...
10/21/2025 13:07:57

Webus International Limited ("Webus" or the "Company") (NASDAQ:WETO), a Nasdaq-listed TravelTech innovator, tod...

big-sky-montana-tops-2026-trending-travel-list-with-92-surge-in-interest
Big Sky, Montana Tops 2026 Trending Travel...
10/19/2025 06:16:15

Big Sky, Montana tops Expedia's list of trending 2026 travel spots, leading a global surge in search interest among travelers.

deep-dive-into-expedia-group-stock-analyst-perspectives-20-ratings
Deep Dive Into Expedia Group Stock: Analys...
10/17/2025 21:01:30

heres-how-much-you-would-have-made-owning-expedia-group-stock-in-the-last-5-years
Here's How Much You Would Have Made Owning...
10/14/2025 15:45:29

btig-reiterates-buy-on-expedia-group-maintains-250-price-target
BTIG Reiterates Buy on Expedia Group, Main...
10/14/2025 11:12:09

BTIG analyst Jake Fuller reiterates Expedia Group (NASDAQ:EXPE) with a Buy and maintains $250 price target.

Core News & Articles
10 Consumer Discretionary Stocks With Whal...
10/10/2025 17:35:56

price-over-earnings-overview-expedia-group
Price Over Earnings Overview: Expedia Group
10/09/2025 15:02:19

wells-fargo-maintains-equal-weight-on-expedia-group-raises-price-target-to-212
Wells Fargo Maintains Equal-Weight on Expe...
10/06/2025 14:14:11

Wells Fargo analyst Ken Gawrelski maintains Expedia Group (NASDAQ:EXPE) with a Equal-Weight and raises the price target from...

beyond-the-numbers-18-analysts-discuss-expedia-group-stock
Beyond The Numbers: 18 Analysts Discuss Ex...
09/30/2025 19:01:29

mizuho-initiates-coverage-on-expedia-group-with-neutral-rating-announces-price-target-of-240
Mizuho Initiates Coverage On Expedia Group...
09/30/2025 16:14:08

Mizuho analyst Lloyd Walmsley initiates coverage on Expedia Group (NASDAQ:EXPE) with a Neutral rating and announces Price Ta...

1000-invested-in-expedia-group-5-years-ago-would-be-worth-this-much-today
$1000 Invested In Expedia Group 5 Years Ag...
09/29/2025 20:45:26

Expedia Group (NASDAQ: EXPE) has outperformed the market over the past 5 years by 4.35% on an annualized basis producing an ave...

jim-cramer-spotlights-these-undervalued-sp-500-stocks-with-growth-potential-amid-skyrocketing-market
Jim Cramer Spotlights These Undervalued S&...
09/23/2025 09:14:41

In a recent episode of "Mad Money," Jim Cramer identified several stocks in the S&P 500 that he believes are underv...

live-on-cnbc-josh-brown-hosts-segment-titled-best-stocks-in-the-market-expedia-group
Live On CNBC, Josh Brown Hosts Segment Tit...
09/18/2025 16:32:27

low-cost-airlines-struggle-while-legacy-rivals-soar-on-global-travel-rebound
Low Cost Airlines Struggle While Legacy Ri...
09/12/2025 18:15:34

JP Morgan analyst Jamie Baker projects strong profitability for US airlines, led by legacy carriers and international travel, w...

17-analysts-have-this-to-say-about-expedia-group
17 Analysts Have This To Say About Expedia...
09/09/2025 12:00:44

btig-reiterates-buy-on-expedia-group-maintains-250-price-target
BTIG Reiterates Buy on Expedia Group, Main...
09/09/2025 10:34:43

BTIG analyst Jake Fuller reiterates Expedia Group (NASDAQ:EXPE) with a Buy and maintains $250 price target.

1000-invested-in-this-stock-20-years-ago-would-be-worth-this-much-today
$1000 Invested In This Stock 20 Years Ago ...
09/08/2025 16:15:18

heres-how-much-1000-invested-in-expedia-group-15-years-ago-would-be-worth-today
Here's How Much $1000 Invested In Expedia ...
09/04/2025 20:15:24

citigroup-maintains-neutral-on-expedia-group-raises-price-target-to-206
Citigroup Maintains Neutral on Expedia Gro...
08/13/2025 11:00:03

Citigroup analyst Ronald Josey maintains Expedia Group (NASDAQ:EXPE) with a Neutral and raises the price target from $177 to...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION